New immune cell combo tackles tough autoimmune diseases
NCT ID NCT06991114
First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This phase 2 trial tests a therapy called AlloNK, made from donor cord blood immune cells, combined with the drug rituximab. It aims to see if this combination is safe and can help people with severe forms of rheumatoid arthritis, Sjögren's disease, myositis, or scleroderma that haven't responded to other treatments. About 90 participants will receive the therapy in a step-by-step dosing plan.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AlloNK (a donor immune cell therapy) combined with rituximab
- What this could lead to
- If it works, this could offer a new treatment option for people with hard-to-treat autoimmune diseases like rheumatoid arthritis or scleroderma.
- What could go wrong
- This is an early phase 2 trial with only 90 people, so results may not apply widely. The therapy involves strong immune suppression, which carries risks of infection and other side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Artiva Investigational Site Arlington
RECRUITINGArlington, Texas, 76012, United States
-
Artiva Investigational Site Belgrade
RECRUITINGBelgrade, Belgrade, Serbia
-
Artiva Investigational Site Bellaire
RECRUITINGBellaire, Texas, 77401, United States
-
Artiva Investigational Site Bonn
RECRUITINGBonn, Bonn, Germany
-
Artiva Investigational Site Brasília
RECRUITINGBrasília, Brasília, Brazil
-
Artiva Investigational Site Brescia
RECRUITINGBrescia, 25125, Italy
-
Artiva Investigational Site Bucharest
RECRUITINGBucharest, 50474, Romania
-
Artiva Investigational Site Bucuresti
RECRUITINGBucharest, 20125, Romania
-
Artiva Investigational Site Bydgoszcz
RECRUITINGBydgoszcz, Bydgoszcz, Poland
-
Artiva Investigational Site Charleston
RECRUITINGCharleston, South Carolina, 29407, United States
-
Artiva Investigational Site Charlotte
RECRUITINGCharlotte, North Carolina, 28207, United States
-
Artiva Investigational Site Charlotte
RECRUITINGCharlotte, North Carolina, 28625, United States
-
Artiva Investigational Site Chula Vista
RECRUITINGChula Vista, California, 92108, United States
-
Artiva Investigational Site Covina
RECRUITINGCovina, California, 91723, United States
-
Artiva Investigational Site Cuiabá
RECRUITINGCuiabá, Cuiabá, Brazil
-
Artiva Investigational Site Gainesville
RECRUITINGGainesville, Georgia, 30501, United States
-
Artiva Investigational Site Hixson
RECRUITINGHixson, Tennessee, 37343, United States
-
Artiva Investigational Site Iowa
RECRUITINGIowa City, Iowa, 52242, United States
-
Artiva Investigational Site Iowa Great Falls
RECRUITINGGreat Falls, Montana, 59405, United States
-
Artiva Investigational Site Irving
RECRUITINGIrving, Texas, 75061, United States
-
Artiva Investigational Site Jackson
RECRUITINGJackson, Tennessee, 38305, United States
-
Artiva Investigational Site Jupiter
RECRUITINGJupiter, Florida, 33458, United States
-
Artiva Investigational Site Katy
RECRUITINGKaty, Texas, 77494, United States
-
Artiva Investigational Site Los Alamitos
RECRUITINGLos Alamitos, California, 90720, United States
-
Artiva Investigational Site Los Angeles
RECRUITINGLos Angeles, California, 90027, United States
-
Artiva Investigational Site Marseille
RECRUITINGMarseille, 13005, France
-
Artiva Investigational Site Mesquite
RECRUITINGMesquite, Texas, 75150, United States
-
Artiva Investigational Site Miami
RECRUITINGMiami, Florida, 33143, United States
-
Artiva Investigational Site Montpellier
RECRUITINGMontpellier, 34090, France
-
Artiva Investigational Site Munchen
RECRUITINGMünchen, 80336, Germany
-
Artiva Investigational Site Norcross
RECRUITINGNorcross, Georgia, 30092, United States
-
Artiva Investigational Site Phoenix
RECRUITINGPhoenix, Arizona, 85037, United States
-
Artiva Investigational Site Plantation
RECRUITINGPlantation, Florida, 33324, United States
-
Artiva Investigational Site Plovdiv
RECRUITINGPlovdiv, Plovdiv, Bulgaria
-
Artiva Investigational Site Porto Alegre
RECRUITINGPorto Alegre, Porto Alegre, Brazil
-
Artiva Investigational Site Red Oak
RECRUITINGRed Oak, Texas, 75154, United States
-
Artiva Investigational Site Rio Grande
RECRUITINGRio Grande, Porto Alegre, Brazil
-
Artiva Investigational Site Roanoke
RECRUITINGRoanoke, Virginia, 24016, United States
-
Artiva Investigational Site Santa Ana
RECRUITINGSanta Ana, California, 92706, United States
-
Artiva Investigational Site Sao Paulo
RECRUITINGSão Paulo, São Paulo, Brazil
-
Artiva Investigational Site Sevila
RECRUITINGSeville, 41701, Spain
-
Artiva Investigational Site Sofia
RECRUITINGSofia, 1612, Bulgaria
-
Artiva Investigational Site Statesville
RECRUITINGStatesville, North Carolina, 27103, United States
-
Artiva Investigational Site São Paulo
RECRUITINGSão Paulo, São Paulo, Brazil
-
Artiva Investigational Site Toulouse
RECRUITINGToulouse, 31059, France
-
Artiva Investigational Site Tucson
RECRUITINGTucson, Arizona, 85748, United States
-
Artiva Investigational Site Tuscaloosa
RECRUITINGTuscaloosa, Alabama, 35406, United States
-
Artiva Investigational Site Tustin
RECRUITINGTustin, California, 92780, United States
-
Artiva Investigational Site Vila Nova De Gaia
RECRUITINGVila Nova de Gaia, 4434, Portugal
-
Artiva Investigational Site Warszawa
RECRUITINGWarsaw, Warszawa, Poland
-
Artiva Investigational Site Willowbrook
RECRUITINGWillowbrook, Illinois, 60527, United States
-
Artiva Investigational Site Woodland
RECRUITINGWoodland, Texas, 77382, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can skin biopsies unlock new treatments for scleroderma?
- Could a skin patch ease stomach pain in scleroderma?
- Could a painless microneedle pad ease Raynaud's in scleroderma?
- Can a new injection calm Sjogren's nerve damage?
- Could a simple blood test flag heart risk in rheumatoid arthritis?
- Learning to Self-Care: a new approach to ease RA stiffness?